J Am Geriatr Soc · Agnihotri P, Telfer M, Butt Z, Jella A, Cella D, Kozma CM, Ahuja M, Riaz S, Akamah J.
Acceder al documento →Rev Esp Cardiol · Carlos Caramelo, Soledad Justo y Paloma Gil
Acceder al documento →J Clin Invest · De Domenico I, Ward DM, Kaplan J.
Acceder al documento →Br J Haematol · Weizer-Stern O, Adamsky K, Margalit O, Ashur-Fabian O, Givol D, Amariglio N, Rechavi G.
Acceder al documento →Vox Sang · J. A. García-Erce, J. Cuenca, S. R. Leal-Noval, M. Muñoz
Acceder al documento →Can J Anaesth · Karkouti K, Beattie WS, Crowther MA, Callum JL, Chun R, Fremes SE, Lemieux J, McAlister VC, Muirhead BD, Murkin JM, Nathan HJ, Wong BI, Yau TM, Yeo EL, Hall RI.
Acceder al documento →Pharmacotherapy. · Kristeller JL, Stahl RF, Roslund BP, Roke-Thomas M.
Acceder al documento →J Trauma · Plurad D, Martin M, Green D, Salim A, Inaba K, Belzberg H, Demetriades D, Rhee P.
Acceder al documento →Vox Sang · Shehata N, Naglie G, Alghamdi AA, Callum J, Mazer CD, Hebert P, Streiner D, Wilson K.
Acceder al documento →Circulation · Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT
Acceder al documento →J Biol Chem · Wang W, Di X, D'Agostino RB, Torti SV, Torti FM.
Acceder al documento →Intensive Care Med · Kneyber MC, Hersi MI, Twisk JW, Markhorst DG, Plötz FB.
Acceder al documento →Transfusion · Hans Gombotz , Peter H. Rehak , Aryeh Shander , and Axel Hofmann
Acceder al documento →Crit Care · Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF.
Acceder al documento →Plast Reconstr Surg · Rinker BD, Bowling JT, Vasconez HC.
Acceder al documento →Best Pract Res Clin · Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR.
Acceder al documento →transfusion · Wong CJ, Vandervoort MK, Vandervoort SL, Donner A, Zou G, Macdonald JK, Freedman J, Karkouti K, Macdonald SJ, Feagan BG.
Acceder al documento →Med Hypotheses · Burk R.
Acceder al documento →Ann R Coll Surg Engl · Lidder PG, Sanders G, Whitehead E, Douie WJ, Mellor N, Lewis SJ, Hosie KB.
Acceder al documento →Lancet · Lancet. 2007 May 19;369(9574):1724-30. Related Articles, Links Comment in: Lancet. 2007 Aug 18;370(9587):562-3; author reply 563-4. Lancet. 2007 Aug 18;370(9587):563; author reply 563-4. Lancet. 2007 May 19;369(9574):1670-1. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Edgren G, Hjalgrim H, Reilly M, Tran TN, Rostgaard K, Shanwell A, Titlestad K, Adami J, Wikman A, Jersild C, Gridley G, Wideroff L, Nyrén O, Melbye M. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. BACKGROUND: Although mechanisms for detection of short-term complications after blood transfusions are well developed, complications with delayed onset, notably transmission of chronic diseases such as cancer, have been difficult to assess. Our aim was to investigate the possible risk of cancer transmission from blood donors to recipients through blood transfusion. METHODS: We did a register-based retrospective cohort study of cancer incidence among patients who received blood from donors deemed to have a subclinical cancer at the time of donation. These precancerous donors were diagnosed with a cancer within 5 years of the donation. Data from all computerised blood bank registers in Sweden and Denmark gathered between 1968 and 2002 were merged into a common database. Demographic and medical data, including mortality and cancer incidence, were ascertained through linkages with nationwide, and essentially complete, population and health-care registers. The risk of cancer in exposed recipients relative to that in recipients who received blood from non-cancerous donors was estimated with multivariate Poisson regression, adjusting for potential confounding factors. FINDINGS: Of the 354 094 transfusion recipients eligible for this analysis, 12,012 (3%) were exposed to blood products from precancerous donors. There was no excess risk of cancer overall (adjusted relative risk 1.00, 95% CI 0.94-1.07) or in crude anatomical subsites among recipients of blood from precancerous donors compared with recipients of blood from non-cancerous donors. INTERPRETATION: Our data provide no evidence that blood transfusions from precancerous blood donors are associated with increased risk of cancer among recipients compared with transfusions from non-cancerous donors.
Acceder al documento →Gynecol Oncol · Kim YT, Kim SW, Yoon BS, Cho HJ, Nahm EJ, Kim SH, Kim JH, Kim JW.
Acceder al documento →J Arthroplasty · Keating EM, Callaghan JJ, Ranawat AS, Bhirangi K, Ranawat CS.
Acceder al documento →Pharmacotherapy · Voils SA, Harpe SH, Brophy GM.
Acceder al documento →Exp Hematol · Goodnough LT
Acceder al documento →J Cardiothorac Vasc · Capraro L, Kuitunen A, Vento AE, Suojaranta-Ylinen R, Kolho E, Pettila V
Acceder al documento →